ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,375 | 28,747 | 301 | -1,506 | -51,609 |
| Depreciation Amortization | 6,900 | 3,878 | 1,110 | 567 | 148 |
| Income taxes - deferred | -1,877 | -14,459 | N/A | N/A | N/A |
| Accounts receivable | -4,635 | -4,784 | -7,081 | -327 | N/A |
| Other Working Capital | -13,821 | -115 | -11,371 | -127 | 1,817 |
| Other Operating Activity | 15,322 | 8,766 | 11,557 | 1,256 | 1,774 |
| Operating Cash Flow | $17,264 | $22,033 | $-5,484 | $-137 | $-47,870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,183 | -1,120 | -191 | -292 | -720 |
| Purchase Sale Intangibles | -30,500 | -34,634 | N/A | N/A | N/A |
| Other Investing Activity | -30,500 | -34,634 | 20,458 | 0 | 0 |
| Investing Cash Flow | $-32,683 | $-35,754 | $20,267 | $-292 | $-720 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 138,243 | N/A | N/A | N/A |
| Common Stock Issued | 819 | 48,249 | 809 | N/A | 68,894 |
| Common Stock Repurchased | -113 | N/A | -433 | 0 | 0 |
| Other Financing Activity | 360 | -14,839 | -4,065 | 440 | -1,234 |
| Financing Cash Flow | $1,066 | $171,653 | $-3,689 | $440 | $67,660 |
| Beginning Cash Position | 169,037 | 11,105 | 11 | N/A | 38,155 |
| End Cash Position | 154,684 | 169,037 | 11,105 | 11 | 57,225 |
| Net Cash Flow | $-14,353 | $157,932 | $11,094 | $11 | $19,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,264 | 22,033 | -5,484 | -137 | -47,870 |
| Capital Expenditure | -2,183 | -1,120 | -191 | -292 | -720 |
| Free Cash Flow | 15,081 | 20,913 | -5,675 | -429 | -48,590 |